// App-Quantinova.ai

3156 : NGS-based screening for TP53 mutations in circulating cell-free DNA: A first step towards early detection of lung cancers

Researchers

Presenter

  • Patrice H. Avogbe

Principal Investigators

  • Tiffany Delhomme

  • Noemie Leblay

  • Florence Le Calvez-Kelm

  • Priscilia Chopard

  • Valerie Gaborieau

  • Ghislaine Scelo

  • Behnoush Abedi-Ardekani

  • David Zaridze

  • Anush Mukeria

  • Graham Byrnes

  • Paul Brennan

  • Lynnette Fernandez-Cuesta

  • Matthieu Foll

  • James D. McKay

Medical Centers

  • International Agency for Research on Cancer, Lyon, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Small cell lung cancer

  • Solid malignancies

Biomarkers

  • Serpin B3

  • Tumor protein p53

  • Circulating DNA

  • Plasma cell-free DNA

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved